Literature DB >> 5641611

Chronic hemolytic anemia due to cold agglutinins. II. The role of C' in red cell destruction.

R S Evans, E Turner, M Bingham, R Woods.   

Abstract

The sera of four patients with chronic hemolytic anemia due to cold agglutinins deposited C' globulins on normal red cells at 37 degrees C. The circulating cells of the patients were heavily coated with C' complex and were relatively resistant to C' hemolysis by cold agglutinin. Such red cells were removed from the patients' circulation at an exponential rate with (51)Cr t((1/2)) that varied from 7 to 19 days. Normal red cells were removed rapidly by hepatic sequestration during the first hours in the patients' circulation. Thereafter, a slower rate of abnormal destruction occurred which was associated with the accumulation of C' complexes on the red cell and the development of resistance to C' hemolysis by cold agglutinin. Normal red cells coated with sufficient C' complex by action of cold agglutinins in vitro to produce resistance to C' hemolysis by cold agglutinins demonstrated varying degrees of improved survival during the first hours in the circulation of three of the patients. The levels of serum C' were reduced in all four patients with chronic hemolytic anemia due to cold agglutinins. Transfusion of large volumes of normal red cells into two patients further reduced serum C'. (51)Cr-labeled normal red cells survived longer after red cell transfusions than before, because of less rapid destruction during the first hours in the circulation. The reduction in serum C' levels appeared responsible for the improved survival. In subjects without cold agglutinins, the presence of the spleen decreased the survival of red cells from a patient who had previously undergone splenectomy. Splenic removal also predominated in the reduced survival of autologous red cells in one patient. Neither hepatic nor splenic mechanisms predominated in removing autologous C'-coated cells in the other two patients.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5641611      PMCID: PMC297220          DOI: 10.1172/JCI105764

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  IDENTIFICATION OF THE COMPONENTS OF COMPLEMENT PARTICIPATING IN THE ANTIGLOBULIN REACTION.

Authors:  M HARBOE; H J MUELLER-EBERHARD; H FUDENBERG; M J POLLY; P L MOLLISON
Journal:  Immunology       Date:  1963-07       Impact factor: 7.397

2.  Immunization after intravenous injection of small amounts of 51Cr-labelled red cells.

Authors:  P L ADNER; S FOCONI; S SJOLIN
Journal:  Br J Haematol       Date:  1963-07       Impact factor: 6.998

3.  The pattern of erythrocyte destruction in haemolytic anaemia, as studied with radioactive chromium.

Authors:  S M LEWIS; L SZUR; J V DACIE
Journal:  Br J Haematol       Date:  1960-04       Impact factor: 6.998

4.  Removal of incompatible red cells by the spleen.

Authors:  N C JONES; P L MOLLISON; N VEALL
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

5.  Relation between characteristics of blood-group antibodies in vitro and associated patterns of redcell destruction in vivo.

Authors:  M CUTBUSH; P L MOLLISON
Journal:  Br J Haematol       Date:  1958-04       Impact factor: 6.998

6.  Labeling human erythrocytes with radiochromium.

Authors:  M COOPER; C A OWEN
Journal:  J Lab Clin Med       Date:  1956-01

7.  The use of chromium as red-cell tag.

Authors:  D M DONOHUE; A G MOTULSKY; E R GIBLETT; G PIRZIO-BIROLI; V VIRANUVATTI; C A FINCH
Journal:  Br J Haematol       Date:  1955-07       Impact factor: 6.998

8.  The association of Raynaud's phenomena, chronic haemolytic anaemia, and the formation of cold antibodies.

Authors:  D G FERRIMAN; J V DACIE; K D KEELE; J M FULLERTON
Journal:  Q J Med       Date:  1951-07

9.  Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.

Authors:  R S Evans; E Turner; M Bingham
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

10.  Autoimmune hemolytic disease: observations of serological reactions and disease activity.

Authors:  R S Evans; M Bingham; E Turner
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

View more
  11 in total

Review 1.  Tissue-specific autoantibodies in haemolytic anaemia.

Authors:  S Worlledge
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Autoimmune haemolytic anaemias. V. studies on the resistance against complement haemolysis of the red cells of patients with chronic cold agglutinin disease.

Authors:  C P Engelfriet; A E Von dem Borne; D Beckers; E Reynierse; J J Van Loghem
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

3.  Autoimmune haemolytic anaemia. VI. 51 Chromium survival studies in patients with different kinds of warm autoantibodies.

Authors:  C P Engelfriet; E Reynierse; D Beckers; J J van Loghem
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

4.  The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits.

Authors:  D L Brown; P J Lachmann; J V Dacie
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

5.  Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.

Authors:  A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

6.  The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.

Authors:  C J Jaffe; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

7.  Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease.

Authors:  C J Parker; C M Soldato; M J Telen
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.

Authors:  G L Logue; W F Rosse; J P Gockerman
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.

Authors:  J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

Review 10.  Initiation and regulation of complement during hemolytic transfusion reactions.

Authors:  Sean R Stowell; Anne M Winkler; Cheryl L Maier; C Maridith Arthur; Nicole H Smith; Kathryn R Girard-Pierce; Richard D Cummings; James C Zimring; Jeanne E Hendrickson
Journal:  Clin Dev Immunol       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.